Absci Corporation
ABSINASDAQHealthcare● Active
$6.53
+$0.13(+1.95%)
Market Cap$1.0B
P/E Ratio—
52W High$7.34
52W Low$2.24
Absci Corporation (ABSI) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
ABSI · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 7, 2026EPS Actual
-$0.19
Est. -$0.20 · +5.0%
Revenue
$0.00B
Est. $0.00B · -82.9%
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 7, 2026
After Market Close
▲ Beat EPS▼ Miss Revenue✓ 1-Quarter EPS Beat Streak
ABSI reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
—
Rev. $0.58B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.—
Rev. Est.$0.58B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 11, 2026 | -$0.19 | — | — | — | $0.00B | — |
| ▲ Q2 FY2026 | May 7, 2026 | -$0.20 | -$0.19 | +5.0% | $0.00B | $0.00B | -82.9% |
| ▼ Q1 FY2026 | Mar 24, 2026 | -$0.16 | -$0.23 | -43.8% | $0.00B | $0.00B | -51.5% |
| ▼ Q4 FY2025 | Nov 12, 2025 | -$0.19 | -$0.20 | -5.3% | $0.00B | $0.00B | -72.6% |
| ▼ Q3 FY2025 | Aug 12, 2025 | -$0.19 | -$0.24 | -26.3% | $0.00B | $0.01B | -88.5% |
| ▲ Q2 FY2025 | May 13, 2025 | -$0.23 | -$0.21 | +8.7% | $0.00B | $0.00B | -9.3% |
| ▼ Q1 FY2025 | Mar 18, 2025 | -$0.22 | -$0.25 | -13.6% | $0.00B | $0.00B | -86.3% |
| ▼ Q4 FY2024 | Nov 12, 2024 | -$0.19 | -$0.24 | -26.3% | $0.00B | $0.00B | -5.8% |
Q3 FY2026
Aug 11, 2026
EPS Actual
—
EPS Est.
-$0.19
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 7, 2026Beat
EPS Actual
-$0.19
EPS Est.
-$0.20
EPS Surpr.
+5.0%
Revenue
$0.00B
Q1 FY2026
Mar 24, 2026Miss
EPS Actual
-$0.23
EPS Est.
-$0.16
EPS Surpr.
-43.8%
Revenue
$0.00B
Q4 FY2025
Nov 12, 2025Miss
EPS Actual
-$0.20
EPS Est.
-$0.19
EPS Surpr.
-5.3%
Revenue
$0.00B
Q3 FY2025
Aug 12, 2025Miss
EPS Actual
-$0.24
EPS Est.
-$0.19
EPS Surpr.
-26.3%
Revenue
$0.00B
Q2 FY2025
May 13, 2025Beat
EPS Actual
-$0.21
EPS Est.
-$0.23
EPS Surpr.
+8.7%
Revenue
$0.00B
Q1 FY2025
Mar 18, 2025Miss
EPS Actual
-$0.25
EPS Est.
-$0.22
EPS Surpr.
-13.6%
Revenue
$0.00B
Q4 FY2024
Nov 12, 2024Miss
EPS Actual
-$0.24
EPS Est.
-$0.19
EPS Surpr.
-26.3%
Revenue
$0.00B
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.00 | $0.00 | $0.00 | 3 |
| Q3 FY2028 | $0.00 | $0.00 | $0.00 | 3 |
| Q2 FY2028 | $0.00 | $0.00 | $0.00 | 3 |
| Q1 FY2028 | $0.00 | $0.00 | $0.00 | 3 |
| Q4 FY2027 | $-0.68 | $-0.19 | $-0.02 | 2 |
| Q3 FY2027 | $-0.27 | $-0.08 | $-0.01 | 2 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2028 | $0.0B | $0.0B | $0.0B | 4 |
| Q3 FY2028 | $0.0B | $0.0B | $0.0B | 4 |
| Q2 FY2028 | $0.0B | $0.0B | $0.0B | 5 |
| Q1 FY2028 | $0.0B | $0.0B | $0.0B | 2 |
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 3 |
| Q3 FY2027 | $0.0B | $0.0B | $0.1B | 3 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▲ Q2 FY2026 | May 7, 2026 | +5.0% | $5.95 | $5.75 | -3.36% |
| ▼ Q1 FY2026 | Mar 24, 2026 | -43.8% | $2.93 | $3.01 | +2.73% |
| ▼ Q4 FY2025 | Nov 12, 2025 | -5.3% | $3.45 | $3.40 | -1.45% |
| ▼ Q3 FY2025 | Aug 12, 2025 | -26.3% | $2.85 | $2.97 | +4.21% |
| ▲ Q2 FY2025 | May 13, 2025 | +8.7% | $2.93 | $2.96 | +1.02% |
| ▼ Q1 FY2025 | Mar 18, 2025 | -13.6% | $3.21 | $3.08 | -4.05% |
| ▼ Q4 FY2024 | Nov 12, 2024 | -26.3% | $4.28 | $3.64 | -14.95% |
| ▼ Q3 FY2024 | Aug 14, 2024 | -15.8% | $3.88 | $3.73 | -3.87% |
Q2 FY2026-3.36%
Report Date
May 7, 2026
EPS Beat/Miss
+5.0%
Price Before
$5.95
Price After
$5.75
Q1 FY2026+2.73%
Report Date
Mar 24, 2026
EPS Beat/Miss
-43.8%
Price Before
$2.93
Price After
$3.01
Q4 FY2025-1.45%
Report Date
Nov 12, 2025
EPS Beat/Miss
-5.3%
Price Before
$3.45
Price After
$3.40
Q3 FY2025+4.21%
Report Date
Aug 12, 2025
EPS Beat/Miss
-26.3%
Price Before
$2.85
Price After
$2.97
Q2 FY2025+1.02%
Report Date
May 13, 2025
EPS Beat/Miss
+8.7%
Price Before
$2.93
Price After
$2.96
Q1 FY2025-4.05%
Report Date
Mar 18, 2025
EPS Beat/Miss
-13.6%
Price Before
$3.21
Price After
$3.08
Q4 FY2024-14.95%
Report Date
Nov 12, 2024
EPS Beat/Miss
-26.3%
Price Before
$4.28
Price After
$3.64
Q3 FY2024-3.87%
Report Date
Aug 14, 2024
EPS Beat/Miss
-15.8%
Price Before
$3.88
Price After
$3.73
Avg Beat Reaction-1.17%
Avg Miss Reaction-2.90%
Beat Rate2 / 8 quarters
Largest Move-14.95% (Q4 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: ABSI ends December
Absci Corporation (ABSI) most recently reported earnings on May 7, 2026 for Q2 FY2026, posting EPS of $-0.19 — beating the analyst consensus of $-0.20 by +5.0%. The next ABSI earnings date is expected around September 1, 2026.
Each quarter, investors track ABSI earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. ABSI revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
ABSI's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
ABSI earnings · 5 questionsAbsci Corporation's next earnings report is expected around September 1, 2026. ABSI typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; ABSI historically reports after market close (AMC).
ABSI earnings datewhen is ABSI earningsABSI next earnings datewhen does ABSI report earningsABSI earnings calendar
▸ Source: FMP · Absci Corporation SEC filings · US GAAP · Absci Corporation SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026